Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS
about
Mechanisms of Muscle Denervation in Aging: Insights from a Mouse Model of Amyotrophic Lateral SclerosisMesenchymal stem/stromal cells as a delivery platform in cell and gene therapiesTransplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injuryAdvances in using MRI probes and sensors for in vivo cell tracking as applied to regenerative medicineStem cell transplantation for motor neuron disease: current approaches and future perspectivesTrophic factors as modulators of motor neuron physiology and survival: implications for ALS therapyHuman neural stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantationRecent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral SclerosisStem cells in human neurodegenerative disorders--time for clinical translation?Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis.Advances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative DiseasesALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the diseaseClinical applications of mesenchymal stem cells in chronic diseases.The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis.Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1G93A ALS rat but has adverse side effects.Effects of supermagnetic iron oxide labeling on the major functional properties of human mesenchymal stem cells from multiple sclerosis patients.Virally and physically transgenized equine adipose-derived stromal cells as a cargo for paracrine secreted factors.Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.Safety of repeated transplantations of neurotrophic factors-secreting human mesenchymal stromal stem cellsNeuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy.Potential therapeutic drugs and methods for the treatment of amyotrophic lateral sclerosis.Intracerebroventricular injection of encapsulated human mesenchymal cells producing glucagon-like peptide 1 prolongs survival in a mouse model of ALS.Distribution of mesenchymal stem cells and effects on neuronal survival and axon regeneration after optic nerve crush and cell therapy.Mesenchymal stem cells for the treatment of neurodegenerative disease.Concise review: Stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the futureDifferential expression of c-Ret in motor neurons versus non-neuronal cells is linked to the pathogenesis of ALS.Stem cell therapy in neurodegenerative diseases: From principles to practice.Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in Amyotrophic Lateral Sclerosis (ALS)--in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia.Motor neuron trophic factors: therapeutic use in ALS?Stem cell technology for neurodegenerative diseases.Human mesenchymal stem cells - current trends and future prospectiveRecent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical applicationStem cell therapy for amyotrophic lateral sclerosisMesenchymal stem cell-based therapy.Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS)Intraspinal stem cell transplantation for amyotrophic lateral sclerosisIntraspinal bone-marrow cell therapy at pre- and symptomatic phases in a mouse model of amyotrophic lateral sclerosis.Isolation and in vitro propagation of human skeletal muscle progenitor cells from fetal muscle.Myosin VI in skeletal muscle: its localization in the sarcoplasmic reticulum, neuromuscular junction and muscle nuclei.Efficient lentiviral transduction of human mesenchymal stem cells that preserves proliferation and differentiation capabilities.
P2860
Q26783337-AB3FDC09-F805-40AE-8FAE-F60322E076BEQ26799107-F21C848A-4D72-4077-890F-0E59C83D4BD7Q26825854-67FB5191-0505-466B-B352-419DD14492ACQ26863117-DB441829-CA16-421E-8640-5DF2B38D7A21Q26995278-1B089CBA-9736-44F3-AEA3-0F3C5EFC0F00Q26999881-BCE81F02-C6DA-4D63-A2CD-E4D0B182C90EQ27324779-A93C9B5F-976E-4406-95F3-E5C7ED4C13F5Q27338320-F40B1DE9-7BA5-49C7-B51E-1C4F67B8EAA7Q27687068-2A2EDE42-1261-4111-98AC-3BB1A5DD067CQ27687180-CE0B93AF-06D4-4F7B-9273-5670673D5C19Q28067160-D82A72F7-8B6A-4EE4-852F-E346B41E75EDQ28392297-8CBF15C8-8F09-44E3-9DB9-54BDF42717F5Q30437823-9633AB8E-5BC6-42D7-9063-532C441328C2Q33577019-695C02E8-62A2-4320-BE60-7E27E5BC51ECQ33600773-859A2B72-112C-4461-AC71-CEA9B7F30596Q33614899-1711243B-8EFD-42F3-A9D4-B30065565908Q33701056-EA21CEF2-D32F-476A-9332-B1BD7EF0654CQ33919781-57DB415C-D2D6-478E-A969-0252344FDA77Q33939595-269577AD-4AB2-434C-B278-B9C764C3B462Q34222849-9276B196-85B4-43C8-9E6A-BD4835996AE9Q34276055-9A86276B-09C2-449C-AFF3-67AB3587BCE5Q34321059-75411A9D-3441-4932-B7ED-6392D9EAF441Q34408378-4BCA7C77-129E-4458-AD68-7D11E19DAE6CQ34473474-78CEB5EF-96B1-4600-A687-4C551125EBBCQ34478634-46232C8A-6225-4CBA-86EF-3E7E16B11B78Q34903874-21C1D6D3-EA1F-44F1-956D-8BAFBA6A404DQ34997944-EFE3A7AD-426C-40C7-A71F-95BECBB8779AQ34998538-063F3B87-AC0C-487C-A896-314D37707265Q35027903-04BD0D92-E09C-419D-890D-9B0838E206D0Q35224202-F2BB60EE-6862-4133-AE33-D51CD25BD2E9Q35548329-2912D381-96FB-4AFF-A917-9ECB1646C895Q36117618-D0F7EE57-316D-4254-A809-77B03A5BDBEAQ36301821-49173EF3-16CF-4B07-B15B-3F52DC15D5EBQ36546424-01AE5CE4-8078-401D-AE44-3CEB5813FF51Q36603298-24DE0D2F-E046-4A9E-82D2-5090E9B8F372Q36679757-799AB9F8-2E98-4627-A702-60190D3D626CQ36686895-4F7C965D-F69A-4CFC-9E8E-9BDE9D6721E9Q36750768-2B58C1F5-506D-43A1-BA34-B29062A1FBA4Q36850126-6113F4F2-8CF5-4792-B6E3-CDCB8E2E01EAQ36861470-C7FCB432-46CF-4248-A010-D93163F2F691
P2860
Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Direct muscle delivery of GDNF ...... in a rat model of familial ALS
@en
Direct muscle delivery of GDNF ...... n a rat model of familial ALS.
@nl
type
label
Direct muscle delivery of GDNF ...... in a rat model of familial ALS
@en
Direct muscle delivery of GDNF ...... n a rat model of familial ALS.
@nl
prefLabel
Direct muscle delivery of GDNF ...... in a rat model of familial ALS
@en
Direct muscle delivery of GDNF ...... n a rat model of familial ALS.
@nl
P2093
P2860
P356
P1433
P1476
Direct muscle delivery of GDNF ...... in a rat model of familial ALS
@en
P2093
Antonio Hayes
Brandon Shelley
Clive N Svendsen
Craig Tork
Jacalyn McHugh
Masatoshi Suzuki
Patrick Aebischer
P2860
P304
P356
10.1038/MT.2008.197
P577
2008-09-16T00:00:00Z